In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
Finding
Lymph nodes and lymphatic vessels with adjacent blood vessels
Definitive Study Shows That People with Melanoma Do Not Need Immediate Lymph Node Removal

The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma.
In the Lab
Lymphedema can produce uncomfortable swelling in the arms or legs in the months and years following cancer treatment.
Could a Topical Cream Prevent Lymphedema? Study in Mice Suggests Yes

By blocking a source of inflammation in the skin, it may be possible to prevent or treat lymphedema, a common and debilitating cancer complication.
Feature
MSK Nassau
7 Reasons to Come to MSK Nassau for Cancer Care

Learn more about world-class cancer care on Long Island at MSK Nassau.
Q&A
Memorial Sloan Kettering surgeon Prasad Adusumilli
CAR T Cell Therapy Shows Promise for Treating Mesothelioma

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
Through-the-microscope view of a tissue sample
MSK Research Highlights, July 17, 2023

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.
In the Clinic
A hand holding a thin optical fiber giving off a red light.
Light-Activated Drug Destroys Small Prostate Cancers with Fewer Side Effects

A novel treatment for prostate cancer involves a light-sensitive drug that destroys small tumors and the blood vessels that feed them.
Finding
Yonina Murciano-Goroff, Jenny Xue, Bob Li, Piro Lito, and Yulei Zhao.
MSK Researchers Are Learning Why Some Patients Develop Resistance to Targeted Lung Cancer Drug

A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.
Dr. Bob Li
First Drug Targeting HER2-Mutant Non-Small Cell Lung Cancer Approved by FDA

The FDA has approved the drug trastuzumab deruxtecan for the treatment of advanced non-small cell lung cancer driven by mutant HER2. An MSK-led study published in September 2021 contributed to the drug's approval.
Samuel Danishefsky
Memorial Sloan Kettering Enters Agreement to Develop New Cancer Drug

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.
Ingo Mellinghoff, Chair of the Department of Neurology at Memorial Sloan Kettering
Brain Trust: 8 Questions with Ingo Mellinghoff

Ingo Mellinghoff is optimistic about the future of brain cancer treatments as the new Chair of MSK’s Department of Neurology.